Physician profile
Daniel Pischl
NPI 1326350604
$13,390.06
in general payments reported to CMS, 2019-2025
17 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.55 · 2020: $57.92 · 2021: $519 · 2022: $11K · 2023: $1,317 · 2024: $134 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $942 · Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $941.94 |
| Food and Beverage | $752.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,602.98 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $191.96 | 2021-2025 | Vistaseal, Ethicon, Stratafix |
| Stryker Corporation | $101.23 | 2023-2025 | 1688, 1788 |
| Mimedx Group, INC. | $64.82 | 2024 | |
| Davol INC. | $61.30 | 2025 | Phasix Mesh |
| Abbvie INC. | $50.14 | 2021-2023 | |
| Smith+Nephew, INC. | $47.47 | 2020-2021 | |
| Allergan, INC. | $46.64 | 2020-2022 | |
| Conmed Corporation | $35.71 | 2022 | |
| Kerecis Limited | $33.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ossur Americas, INC. | $31.11 | 2024-2025 | |
| Novo Nordisk INC | $30.85 | 2023 | Wegovy |
| Becton, Dickinson and Company | $22.17 | 2024 | Ventralight St |
| Merit Medical Systems INC | $21.80 | 2023 | Savi Brachy, Savi Scout |
| Hologic Sales and Service, LLC | $19.28 | 2023 | Coolseal Generator |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.61 | 2020 | |
| Endogastric Solutions, INC | $12.92 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pischl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.